Analyst Expectations For DexCom's Future
Portfolio Pulse from Benzinga Insights
Analysts have mixed ratings for DexCom (NASDAQ:DXCM), with a recent average 12-month price target of $97.67, down 2.74% from the previous target. The company shows strong financial metrics but faces challenges with high debt levels.
October 25, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
DexCom has received mixed analyst ratings with a slight downward revision in the average 12-month price target. The company's financial performance is strong, but high debt levels are a concern.
The article provides a detailed analysis of DexCom's recent analyst ratings, showing a mix of bullish and bearish perspectives. The average price target has decreased slightly, indicating a neutral short-term impact. DexCom's strong financial metrics are offset by concerns over its high debt levels, leading to a balanced outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100